Overview

Effect of olmesaRtan on Walking distancE and quaLIty of lifE in Peripheral Artery Disease Patients With Hypertension Treated For Intermittent Claudication (RELIEF)

Status:
Terminated

Trial end date:
2015-11-17

Target enrollment:

Participant gender:

Summary

To study the effect of olmesartan on walking distance and quality of life in peripheral artery disease patients with hypertension treated For intermittent claudication.

Phase:

Phase 4

Details

Lead Sponsor:

Yonsei University

Treatments:

Antihypertensive Agents
Olmesartan
Olmesartan Medoxomil